Company intelligence / Profile preview

Naturwohl Pharma

Germany

Ownership: Private
Development stage: Other

Overview

Naturwohl Pharma, before its acquisition, was a leading German dietary supplement maker, best known for Yokebe—a shake/liquid meal replacement for weight management, generating about €30 million in 2015 net sales. The Yokebe brand held the second-largest market share in Germany’s dietary supplement category. No clinical drug programs or clinical trial results identified; focuses on consumer OTC health and nutrition markets

Therapeutic areas: OtherMetabolic Disorders
Modalities: Small molecule
Industry: Food & Nutrition

Partnerships

Omega Pharma (Yokebe distribution/portfolio integration, as part of Perrigo’s European consumer health strategy)

Beyond the preview

Go deeper on Naturwohl Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Naturwohl Pharma.

Explore the full profile